TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies.

Frederick L Locke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.